EvaluatePharma recently forecasted the 10 drugmakers that may have the highest worldwide prescription drug sales by 2026. Here are their predictions:
- Roche ($61 billion)
- Johnson & Johnson ($56.1 billion)
- Novartis ($54.8 billion)
- Merck & Co. ($53.2 billion)
- AbbVie ($52.7 billion)
- Pfizer ($51.1 billion)
- Bristol-Myers Squibb ($44.7 billion)
- Sanofi ($41.7 billion)
- AstraZeneca ($41 billion)
- GlaxoSmithKline ($40.8 billion)
More articles on pharmacy:
NIH updates remdesivir treatment guidelines
J&J to start human trials for COVID-19 vaccine this week
Growing number of polls find Americans hesitant about getting a future COVID-19 vaccine
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
